LIC portfolio rejig: Insurer trims stake in NBCC to 4.5%, hikes ACC stake to nearly 11%
LIC portfolio rejig: According to data on NBCC's shareholding pattern as in September, the President of India is the largest promoter of the company, holding 61.75% stake.
OPINION | When brands use apologies casually, credibility is the real casualty
What began as a creative hack to grab attention has quickly become a gimmick. And like all gimmicks, it risks trivialising something important
Sensex settles 250 pts lower from day’s high, Nifty ends near 26,200: Four key reasons behind market decline
Stock market today: Sensex, Nifty saw profit booking as the pullback was driven by a mix of foreign fund outflows, along with profit-taking in key sectors.
How Labour Code 2025 can shrink your salary, if basic pay is below 50% CTC
Today, most organisations keep basic salary on the lower side, usually around 25 to 40% of the total CTC. The new Labour Codes are set to change how organisations calculate PF and gratuity for its employees.
Adani Enterprises shares rise 2.5% after unit buys 73% stake in Flight Simulation Technique Centre for Rs 820 cr
India's defence pilot training ecosystem is emerging as a major opportunity, mirroring trends in civil aviation where simulator-based training lowers costs and improves safety and efficiency, the company said
India in active FTA discussions with US, talks with Canada kick off next week, says Piyush Goyal
India is in talks with 14 countries or blocs on free trade agreements, the commerce minister has said
Hindustan Zinc shares rise 3% as silver prices surge, stock extends gains for fourth session
Hindustan Zinc share price: Hindustan Zinc is the largest producer of silver in India, and produces refined silver with a minimum 99.9 percent purity
Why many retail investors are not making money even as Nifty, Sensex hit new highs
The benchmark indices are celebrating new highs, but the broader market is still healing. Investors may not see meaningful improvement until the rally broadens across sectors and market caps.
India VIX heads for sharpest weekly fall in six months as market hits record high
The VIX had touched 13.64 on November 21 before sliding steadily to 11.1, marking its sharpest weekly drop since May.
M&M shares rise 2% as Nomura finds new e-SUV priced attractively, sees up to 16% upside
Nomura maintained a ‘buy’ rating on M&M with a price target of Rs 4,355, a 16 percent upside from the current levels.
India to lead growth among emerging markets with 7% GDP rise in 2025: Moody's
Moody's also said that India's domestic growth drivers underpin its economic resilience amid global uncertainty.
Is China winning the innovation race?
Once the world’s factory, Beijing’s relentless focus on R&D means the country has become the world’s laboratory
‘Everybody is waiting for RBI’: Piyush Goyal hints at room for rate cut as inflation hits series low
The commerce minister also urges the industry to bank on self-reliance at a time when 'trade is being weaponised'
Chart of the Day: How competitive is India on the corporate tax front?
The 2019 corporate tax cuts have yielded India a more favourable ranking, but some competing Asian economies continue to enjoy a comparative advantage
Jefferies skeptical about rebound in beaten-down IT stocks, says growth outlook remains uncertain; check its top picks
Growth worries and AI-related uncertainty could cap multiples, even if cheaper valuations offer better entry points, says Jefferies
Buy Datamatics Global Services; target of Rs 1130: Choice Institutional Equities
Choice Institutional Equities is bullish on Datamatics Global Services has recommended buy rating on the stock with a target price of Rs 1130 in its research report dated November 27, 2025.
Buy Supriya Lifescience; target of Rs 1030: Choice Institutional Equities
Choice Institutional Equities is bullish on Supriya Lifescience has recommended buy rating on the stock with a target price of Rs 1030 in its research report dated November 28, 2025.
63 moons shares rise 16% as National Spot Exchange settlement scheme approved by NCLT
The NCLT approval marks a final stop for the 12-year long NSEL crisis, potentially leading to all legal cases against company being withdrawn.
India Vix eases 19% in five days, signals steady risk appetite; analysts see Nifty support at 26,000-26,100
The broader market structure remains positive, with repeated affirmations of strong support zones on the Nifty. Further, the market strength is supported by earnings momentum and improving macro indicators.
Neutral NTPC; target of Rs 370: Motilal Oswal
Motilal Oswal recommended Neutral rating on NTPC with a target price of Rs 370 in its research report dated November 27, 2025.
MC Insider: A CEO race, conglomerate shake-ups and a capital shift
Track the drama, deals and decision-making playing out away from the public eye
Buy Privi Speciality Chemicals; target of Rs 3960: Motilal Oswal
Motilal Oswal is bullish on Privi Speciality Chemicals recommended buy rating on the stock with a target price of Rs 3960 in its research report dated November 28, 2025.
Sensex gains 300 pts from day's low, Nifty above 25,250: Hopes of higher GDP among key factors behind market rise
Stock market today: Sensex, Nifty rose tracking positive cues ahead of the release of the July–September quarter GDP numbers, due after market hours.
Buy Eureka Forbes; target of Rs 700: ICICI Securities
ICICI Securities is bullish on Eureka Forbes recommended buy rating on the stock with a target price of Rs 700 in its research report dated November 28, 2025.
